Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin XR vs IR in Type 2 Diabetes
NCT01864174Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Jun 2013; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01864174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864174.